OSTEOPOROSIS

✓ Medically ReviewedDISEASEID: MDBT0140🚨 TRIAGE: ROUTINEICD-10: M81.9

📖

Definition

CLINICAL DEFINITION

Osteoporosis is systemic skeletal disease (whole-skeleton bone disease) with low mass and microstructure decay. Microstructure means tiny internal framework that provides strength. Resorption (breakdown by osteoclasts which remove bone) exceeds formation (building by osteoblasts which make bone). WHO defines it by DXA T-score (density score versus young adult mean) at or below minus 2.5 at spine or hip. Fragility fractures (breaks from minor trauma) cluster at spine, hip and wrist.

IN PLAIN ENGLISH

Bones grow thin and weak. Tiny holes form inside bone. Bones break with small falls. Spine, hip and wrist break most. Pain is rare till a break. Food, movement and care cut risk.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Osteoporosis is not osteoarthritis (joint wear with pain and stiffness). It is not osteomalacia (soft bone from poor mineralisation with vitamin D lack). It is not cancer spread or bone infection (germ invasion with fever). Pain alone without low density or fragility fracture does not define it.

🔤

Word Breakdown

osteo-

=bone meaning skeletal tissue

por-

=pore meaning small opening that makes bone spongy

-osis

=condition meaning chronic disease process

Literal Meaning: porous bone condition that breaks easily

🏷️

Abbreviations

DXA=Dual-energy X-ray absorptiometry - low-dose scan that measures bone density

BMD=Bone mineral density - mineral amount per bone area that reflects strength

FRAX=Fracture risk assessment tool - calculator that estimates future fracture chance

VFA=Vertebral fracture assessment - spine image check for silent crush fractures

🔄

Synonyms & Variants

Porous bone disease›Fragility bone disease›Brittle bone disease›

🎯

Category-Specific Context

Osteoporosis is a Disease because it is a lasting pathologic state (disease-driven bone failure) with events and staging. It is not a single Symptom (patient complaint) or Sign (exam finding). It produces fragility fractures (breaks from minor trauma) needing long term care. Disease coding prompts density testing with secondary cause search. It sits under metabolic bone disease (chemistry-driven bone group).

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Primary Care for Screening and PreventionEndocrinology and Rheumatology Clinic for Secondary WorkupGeriatrics Service for Frailty and FallsFracture Liaison Service after Fragility FractureEmergency Care for Hip, Spine or Wrist Fracture

USAGE & DOCUMENTATION NOTES

Use osteoporosis after DXA confirmation (low-dose density scan) or typical fragility fracture with risk factors. Document site with trauma level and T-score (density score) plus FRAX result (fracture risk estimate). State secondary risks with drugs, smoking and alcohol. Avoid labelling isolated back pain as osteoporosis without bone evidence. Record height loss with falls and function each visit.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

Oestrogen loss at menopause (stopping of periods) raises osteoclast activity (bone removal) and shortens osteoblast life (bone building). Resorption outpaces formation so trabecular plates (spongy inner bone) thin and disconnect. Cortical bone (dense outer shell) thins with more porosity (tiny holes). Microdamage accumulates and stiffness falls. Minor load then causes vertebral, hip or wrist fracture. Secondary drivers such as steroids (steroid drugs) with thyroid excess and gut failure speed the same loop.

PRIMARY CAUSES

Postmenopausal oestrogen deficiency

Oestrogen loss raises osteoclast drive and lowers osteoblast work so breakdown exceeds building and spongy bone is lost fast

Age-related bone loss

Ageing slows osteoblast formation and impairs calcium uptake so microdamage accumulates and density falls

Chronic glucocorticoid excess

Steroid excess suppresses osteoblast growth and prolongs osteoclast life plus lowers gut calcium uptake so loss is rapid

Primary hyperparathyroidism

Excess parathyroid hormone drives osteoclast resorption to release calcium so bone is removed to raise blood calcium

Hyperthyroidism

Excess thyroid hormone speeds turnover with resorption outpacing formation so density falls and fracture risk rises

Hypogonadism

Low sex hormones reduce osteoblast activity and raise resorption so mass falls in younger and older adults

Malabsorption with calcium and vitamin D lack

Poor gut uptake lowers calcium and vitamin supply so hardening fails and parathyroid drive removes bone

Chronic kidney disease (long term kidney failure)

Failing kidneys disturb calcium with phosphate and vitamin D balance so parathyroid drive rises and quality falls

Rheumatoid arthritis

Chronic joint inflammation with immune signals plus reduced mobility and steroid use speeds bone loss

Smoking with excess alcohol use

Toxins with poor nutrition impair osteoblast work and hormone balance plus raise fall risk so fractures increase

💊

Drug-Induced Causes

💊 Systemic glucocorticoids (prednisolone, dexamethasone) ↗

Mechanism: Suppress osteoblast formation and raise osteoclast survival with lower gut calcium uptake causing rapid spine and hip loss

→ Use lowest effective dose for shortest time, assess fracture risk early, arrange DXA with bone protection and calcium and vitamin D review

💊 Proton pump inhibitors (omeprazole, lansoprazole) ↗

Mechanism: Long term acid suppression may lower calcium uptake with modest link mainly in chronic use

→ Review need, use lowest effective dose, ensure calcium and vitamin D intake with DXA review in high risk users

💊 Selective serotonin reuptake inhibitors (fluoxetine, sertraline) ↗

Mechanism: Serotonin signals affect osteoblast and osteoclast balance with long term link to lower density and more falls

→ Review mood care, assess fall and fracture risk, arrange bone health review without stopping needed therapy alone

💊 Gonadotropin-releasing hormone agonists ↗

Mechanism: Lower sex hormones to very low levels so resorption rises fast like menopause

→ Plan density monitoring, ensure calcium and vitamin D intake, add bone protective therapy when prolonged per specialist guidance

💊 Aromatase inhibitors (anastrozole, letrozole) ↗

Mechanism: Block oestrogen production in postmenopausal women so protection is lost and resorption rises

→ Check baseline DXA with fracture risk, ensure exercise with calcium and vitamin D, start bone protection when risk is high

💊 Enzyme-inducing antiseizure medicines (phenytoin, carbamazepine) ↗

Mechanism: Raise vitamin D breakdown and lower calcium uptake with direct bone cell effects so density falls in chronic use

→ Monitor vitamin D with density, supplement when low, review neurology care before any change

🌍

Epidemiology

Prevalence:Osteoporosis is very common worldwide and rises with population ageing. Steep rise occurs after midlife in both sexes. Highest burden is in postmenopausal women (women after periods stop) from oestrogen loss. Older men and glucocorticoid (steroid drug) users are also affected. Rates vary by diet, vitamin D status and screening practice.

Age Group:Osteoporosis mainly affects older adults past midlife. Risk climbs steadily with advancing age in both sexes. Postmenopausal women (women after periods stop) carry highest risk from rapid oestrogen (female hormone) loss. Men develop disease later often with secondary causes such as hypogonadism (low sex hormones) or steroids. Young cases suggest secondary disease and need full workup.

Sex Predilection:Female

Geographic Distribution:Osteoporosis occurs worldwide in all populations. Higher detection occurs where DXA screening (density scanning) with ageing populations is common. Low calcium intake with low sunlight and indoor lifestyle raises burden. Regional fracture patterns vary with falls, frailty and care access.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 ROUTINE

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

New fragility fracture as first presentation needing same-episode bone workup
Myeloma or metastases that mimic diffuse loss
High calcium with parathyroid disease or cancer
Falls with frailty and steroid use that drive repeat harm
Cord compression (spinal cord pressure) with weakness, numbness or bladder change

URGENT EVALUATION TRIGGERS

Severe back pain after minor trauma suggesting vertebral fracture
Hip pain with inability to bear weight after fall
New leg weakness, numbness or bladder change suggesting cord compression
High calcium symptoms such as thirst, confusion or stones

Contraindications & Precautions

CONTRAINDICATIONS

Avoid prolonged bed rest and immobilisation without clot and bone review
Avoid high-trauma sports with heavy twisting lifts without guidance in severe disease
Avoid smoking with excess alcohol that impair bone healing
Do not stop bone protective therapy without medical review

SPECIAL PRECAUTIONS

Fall-proof home with lighting, rails, vision and footwear review
Encourage weight-bearing with balance exercise within safe ability
Ensure adequate calcium with vitamin D intake per guidance
Review sedatives with vision, standing pressure and walking aids

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Vertebral compression fracture with pain, height loss and kyphosis (forward hunch)
Hip fracture with immobility, surgery need and high harm in frail elders
Distal radius (wrist) and limb fractures after minor falls
Chronic pain with deconditioning and loss of independence
Repeat fragility fractures with progressive deformity

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Osteomalacia

Sounds like osteoporosis and both cause fragility but osteomalacia is soft bone from poor mineralisation (hardening failure) from vitamin D lack

Osteomyelitis

Shares osteo prefix with bone pain but means bone infection with fever and raised inflammation markers

Osteoarthritis

Shares osteo start in older adults but means joint cartilage wear with pain and stiffness, not low bone mass

Osteopetrosis

Opposite density change with similar name but means dense brittle marble bone from failed resorption

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Osteomalacia

Key Distinguishing Feature: Low vitamin D with high alkaline phosphatase and Looser zones (stress lines) plus muscle weakness from poor mineralisation

Multiple myeloma

Key Distinguishing Feature: Lytic punched-out lesions (eaten-away spots) with anaemia and monoclonal protein (abnormal antibody)

Bone metastases

Key Distinguishing Feature: Focal destructive lesions with known primary cancer and raised calcium, not diffuse loss alone

Primary hyperparathyroidism

Key Distinguishing Feature: High calcium with high parathyroid hormone and low phosphate while primary osteoporosis has normal calcium

Osteogenesis imperfecta

Key Distinguishing Feature: Genetic collagen defect with blue sclerae (blue eye whites) and early fractures in youth

💎

Clinical Pearls

💎

Check lateral spine imaging when height loss or back pain occurs because many vertebral fractures are silent and change therapy.

💎

Always search secondary causes with drug review plus calcium, vitamin D, kidney, thyroid and parathyroid labs before labelling primary disease.

💎

Combine DXA T-score (density score) with FRAX (risk calculator) and clinical risks because fractures occur even in osteopenia (low mass above osteoporosis range).

💎

Counsel on protein with calcium, vitamin D, balance training and smoking cessation alongside drug therapy for best protection.

💎

Arrange dental review before potent antiresorptive therapy (bone-loss blockers) and report jaw pain, swelling or loose teeth promptly.

📝

Example Usage & SOAP

CLINICAL SENTENCE

""74-year-old woman with wrist break after small trip has postmenopausal osteoporosis.""

IN A SOAP NOTE

S: 74-year-old woman with back ache after lifting shopping, no trauma or fever or weight loss, known height loss. O: Temp 36.6C, BP 142/84, HR 78, RR 16, SpO2 98 percent on air, spine tender, height down 3 cm, gait steady. A: Likely severe osteoporosis with suspected vertebral fracture. P: Arrange spine X-ray with DXA, check calcium, vitamin D, kidney, thyroid and parathyroid labs, start calcium and vitamin D review, physio with falls plan and bone protection decision.

DIFFERENTIAL DIAGNOSIS CONTEXT

Diffuse low density with fragility fracture favours osteoporosis over metastases. Focal destructive lesion with known cancer favours metastases. Anaemia with lytic spots and monoclonal protein favours myeloma. Muscle weakness with low vitamin D favours osteomalacia. High calcium with high parathyroid hormone favours hyperparathyroidism. Use DXA with labs and spine imaging to separate causes.

📊

Classifications & Scoring

GRADING SYSTEM

WHO bone density classification

Uses DXA T-score of spine or hip with normal above minus 1 and low mass to minus 2.5 and osteoporosis at or below minus 2.5 with severe disease when fracture present

SCORING TOOL

FRAX fracture risk tool

Estimates future hip and major fracture chance using age, sex, weight, prior fracture, family history, smoking, steroids, arthritis, alcohol and femoral density when available

SCORING TOOL

Garvan fracture risk calculator

Estimates future fracture chance using age, prior fracture count, falls and bone density for counselling

📈

Prognosis

SHORT-TERM OUTCOME

Without fracture, short term function is often preserved. With hip or vertebral fracture, pain and immobility are common. Early mobilisation with pain control and rehab improves recovery. New fragility fracture should prompt rapid bone and fall review. Short term harm tracks frailty and fall risk.

LONG-TERM PROGNOSIS

Long term course is chronic but modifiable with therapy and lifestyle care. Bone protective therapy lowers vertebral and hip fracture risk over years. Ongoing falls with frailty, smoking and steroids worsen outlook. Repeat fractures raise disability and care needs. Sustained follow up with density and risk review supports independence.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

M81.9

LITERATURE CITATIONS & GUIDELINES

[1]WHO ICD-10 M81 Osteoporosis without pathological fracture

[2]NICE guidance on osteoporosis

[3]Endocrine Society osteoporosis guidance

[4]Harrison's Principles of Internal Medicine metabolic bone disease

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.